Cargando…
YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence
Attempts to identify biomarkers to detect prostate tumorigenesis, and thus minimize prostate cancer progression and inform treatment decisions have primarily focused on alterations at the DNA and mRNA levels, ignoring alterations at the level of protein synthesis control. We have previously shown th...
Autores principales: | Sheridan, Christine Moore, Grogan, Tristan R., Nguyen, Hao G., Galet, Colette, Rettig, Matthew B., Hsieh, Andrew C., Ruggero, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480693/ https://www.ncbi.nlm.nih.gov/pubmed/25797255 |
Ejemplares similares
-
YB-3 substitutes YB-1 in global mRNA binding
por: Lyabin, D. N., et al.
Publicado: (2020) -
Expression of MTA1 in endometriosis and its relationship to the recurrence
por: Zhang, Jing, et al.
Publicado: (2018) -
Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells
por: Liu, Teresa T., et al.
Publicado: (2015) -
Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans
por: Dias, Steven J., et al.
Publicado: (2013) -
Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone
por: Liu, Sandy, et al.
Publicado: (2016)